Cite

    Ediriwickrama, N. et al. (2019). The combination of an inclusive novel agent treatment strategy, pre‐emptive therapy dose reduction, and prolonged therapy results in good outcomes in elderly myeloma patients. British journal of haematology. pp. e11-e13. [Online].